000			01409 a2200373 4500
005			20250515120013.0
264		0	_c20080605
008			200806s 0 0 eng d
022			_a1812-9269
040			_aNLM _beng _cNLM
100	1		_aBerezhnaya, N M
245	0	0	_aThe use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin. _h[electronic resource]
260			_bExperimental oncology _cMar 2008
300			_a52-5 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aKiller Cells, Lymphokine-Activated _xdrug effects
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMelanoma, Experimental _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeoplasm Transplantation _ximmunology
650	0	4	_aRhabdomyosarcoma _xdrug therapy
650	0	4	_aTumor Escape _xdrug effects
700	1		_aVinnichuk, Yu D
700	1		_aBelova, O B
773	0		_tExperimental oncology _gvol. 30 _gno. 1 _gp. 52-5
999			_c17935167 _d17935167